InVivo Therapeutics Holdings Corp. (OTC:NVIV) appointed spinal cord injury expert Dr. Edward Wirth as its new chief scientist.
InVivo brings Wirth to the team as its waiting for a green light by the FDA to begin human trials of its biodegradable scaffold for treating spinal cord injury.
The scaffold is designed to protect and support spinal tissue and prevent secondary injury, including inflammation and glial scarring, following traumatic spinal cord injury.
"I’ve been impressed with the cutting-edge work and laboratory data developed by the InVivo team, and I firmly believe the use of InVivo’s platform of implantable biopolymer scaffold technologies is the future of SCI treatment," Wirth said in prepared remarks.
If given the green light by the federal watchdog agency, InVivo would begin a 10-patient trial in early 2012. Trial subjects would join the study within a day or so of being injured, InVivo CEO Frank Reynolds told MassDevice.
Here are the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Iridex’s Boutacoff resigns
Theodore Boutacoff, President & CEO of Iridex Corp. stepped down, transitioning to chief technology officer. Dominik Beck will replace Boutacoff in the corner office.
- Avedro appoints new doc to its advisory board
Avedro Inc. appointed A. John Kanellopoulos to its medical advisory board. Kanellopoulos is a clinical professor of ophthalmology at the NYU School of Medicine and director of the Athens, Greece-based Laser Vision Institute.
- Cardiac Dimensions names a new VP
Kirkland, Wash.-based Cardiac Dimensions named Omari Bouknight as its new vice president of sales and marketing.
- LumaMed adds to board of directors
LumaMed appointed Mass. General Hospital doc R. Rox Anderson to its board of directors.
- Former OmniSonics exec joins Reflectance Medical
Physiological sensor company Reflectance Medical Inc. named med-tech veteran Rich Ganz as its new CEO.
- Acclaris appoints chief growth officer
Acclaris, appointed healthcare insurance industry veteran Jim Priebe to the newly created position of Chief Growth Officer.
- Biolase Technology appoints new VP
Dental laster manufacturer Biolase Technology Inc. appointed its director of operations Richard Whipp to the newly created position of vice president of operations.
- Greatbatch elects Bihl to its board of directors
Greatbatch Inc. elected Anthony Bihl III to its board of directors. Bihl also will serve on the board’s corporate governance & nominating and technology development & innovation committees.